Friday, May 1, 2026

AI-Generated Ghibli Art Boosts ChatGPT’s Growth as Global Users Surpass 500 Million

ChatGPT's daily active users in South Korea hit 1.4 million, driven by Ghibli-style images, marking a global surge in popularity.

How Dongkoo Bio & Pharma Plans to Conquer Southeast Asia’s Aesthetic Market with DERMAROSA

Dongkoo Bio & Pharma partners with Areum Medics and Adization Inc. to expand its global aesthetic market presence with Dermarosa.

Presidential Bodyguard Accused of Groping Woman on Subway!

The Presidential Security Service announced today that it would proceed with disciplinary procedures according to relevant regulations.

Tag: trial

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

Revolutionary TNZ Alloy Implants: 4x Stronger Than Titanium for Better Dental Health

Korean researchers have developed a next-gen implant alloy that outperforms titanium, mimicking bone properties and ensuring higher strength.

Unlock Healthier Hair: JW Shinyak’s Ducray Neoptide Expert Shows 93.6% User Satisfaction in Global Study

JW Shinyak's Ducray Neoptide Expert shows significant hair improvement in a global trial, with high user satisfaction across ages and conditions.

Metabia Begins Dosing First Patient in Phase 1 Part 3 Trial of Obesity Drug DA-1726

Metabia begins Phase 1 trial for DA-1726, a dual-action obesity treatment, aiming for safety and efficacy in weight loss by 2026.

Daewoong Pharmaceutical Expands Indication for Fexuclue: What This Means for 2026

Daewoong Pharmaceutical submits Phase 3 trial plan for Fexuclue to treat gastric ulcers, aiming to enhance treatment options and patient quality of life.

First Patient Registered in Vietnam: A Milestone for Dengue Treatment Trials by Hyundai BioScience

Hyundai Bio Science has registered its first patient for a dengue treatment trial in Vietnam, marking a significant milestone.

Your Guide to Jaqbo: The New GERD Treatment Shaping the Future of Chronic Care

Onconic Therapeutics begins a Phase 3 trial for Jaqbo, aiming to expand GERD treatment options and enhance long-term management strategies.

Is VRN110755 the Future of Non-Small Cell Lung Cancer Treatment? Find Out!

Voronoi's VRN110755 for NSCLC receives approval for clinical trial modifications, expanding to a Phase 1b/2 trial across multiple regions.

DA-1726: The New Dual-Action Obesity Treatment Set to Transform Weight Loss in 2026

MetaVia's DA-1726 obesity treatment trial approved by U.S. IRB, focusing on dual-action GLP-1 and Glucagon receptors for weight loss.

Celltrion’s CT-P55: What Changes to FDA Clinical Trials Mean for Biosimilarity with Cosentyx?

Celltrion has applied to the FDA for changes to its Phase 3 trial of CT-P55, reducing participants to 153 to assess biosimilarity to Cosentyx.

New Fat Reduction Injection Shows 73.7% Success in Phase 3 Trial

AMIPHARM reveals promising phase 3 results for AYP-101, a fat reduction injection, at IMCAS 2026, targeting submental fat safely.

Medipost’s CARTISTEM® Completes Phase 3 Trials in Japan: What This Means for Knee Osteoarthritis Treatment

Medipost completes Phase 3 trial for CARTISTEM in Japan, targeting knee osteoarthritis treatment and planning U.S. trial enrollment soon.

Discover the Breakthrough: Daewoong’s CleanCol Tablet Reduces Dosage for Effective Colon Cleansing

Daewoong Pharmaceutical's Cleancol Tab. shows effective bowel cleansing with fewer tablets, improving patient adherence during colonoscopy prep.

GCC2005: The Breakthrough CAR-NK Therapy for T-Cell Lymphoma Unveiled at TCLF 2026

GC Cell presents promising CD5-targeting CAR-NK therapy GCC2005 for T-cell lymphoma, showing significant efficacy and safety at TCLF.

HM15275 Clinical Trials: What You Need to Know About This Groundbreaking Obesity Treatment

Hanmi Pharmaceutical's HM15275 enters Phase 2 trial, aiming to revolutionize obesity treatment and diabetes management by 2030.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.